Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.

[1]  D. Carson,et al.  Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.

[2]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[3]  A. Hagenbeek,et al.  Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Wacholder,et al.  Second cancers among long-term survivors of non-Hodgkin's lymphoma. , 1993, Journal of the National Cancer Institute.

[5]  K. Schallreuter,et al.  Cutaneous malignant melanomas with other coexisting neoplasms: a true association? , 1993, Dermatology.

[6]  B. Hankey,et al.  Second cancers in patients with chronic lymphocytic leukemia. , 1992, Journal of the National Cancer Institute.

[7]  G. Eklund,et al.  Occurrence of other malignancies in 1973 patients with basal cell carcinoma. , 1991, Journal of the American Academy of Dermatology.

[8]  A. Cnaan,et al.  Are malignant melanoma patients at higher risk for a second cancer? , 1991, Cancer.

[9]  B. Hankey,et al.  Second cancers following non‐Hodgkin's lymphoma , 1991, Cancer.

[10]  U. Ringborg,et al.  Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. , 1990, American journal of epidemiology.

[11]  Shona M. Barcus.  The guide to mental health for nurses in primary care , 2003, International Journal of Integrated Care.

[12]  D. Reintgen,et al.  Malignant melanoma arising during pregnancy. A study of 100 patients. , 1990, Annals of surgery.

[13]  M. Tucker,et al.  The Danish case‐control study of cutaneous malignant melanoma. II. Importance of UV‐light exposure , 1988, International journal of cancer.

[14]  A. Kopf,et al.  Risk factors for the development of malignant melanoma--I: Review of case-control studies. , 1988, The Journal of dermatologic surgery and oncology.

[15]  U. Ringborg,et al.  Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. , 1987, Journal of the National Cancer Institute.

[16]  M. Tucker,et al.  Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. , 1985, National Cancer Institute monograph.

[17]  E. Saxén,et al.  Multiple cancer--an epidemiologic exercise in Finland. , 1985, Journal of the National Cancer Institute.

[18]  C. N. Coleman,et al.  Cutaneous malignant melanoma after Hodgkin's disease. , 1985, Annals of internal medicine.

[19]  B Mattsson,et al.  Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. , 1984, Acta radiologica. Oncology.

[20]  J. A. Lee.  Melanoma and exposure to sunlight. , 1982, Epidemiologic reviews.

[21]  B. Schoenberg,et al.  Malignant Melanoma Associated With Breast Cancer , 1980, Southern medical journal.

[22]  G. Moore,et al.  Estrogen receptor proteins in diverse human tumors. , 1980, Archives of surgery.

[23]  P. Hersey,et al.  Low natural-killer-cell activity in familial melanoma patients and their relatives. , 1979, British Journal of Cancer.

[24]  R. Hoover,et al.  Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism. , 1978, Journal of the National Cancer Institute.

[25]  K. Magnus.  Incidence of malignant melanoma of the skin in the five nordic countries: significance of solar radiation , 1977, International journal of cancer.

[26]  H. Shaw,et al.  Multiple primary cancers in patients with malignant melanoma. , 1976, The Medical journal of Australia.